Diamedica (DMAC) Fundamental Analysis: Revenue, Earnings & Valuation

5.72 / 10

Netural

The stock's fundamentals show balanced quality (5.7/10). Favorable features: Asset-MV and Cash-MV, but headwinds are noted in Gross profit margin (%) and Revenue-MV. Analytical stance: moderate.

Analysis Checks(8/10)

Revenue-MV

Value-0.18

Score1/3

Weight10.78%

1M Return4.20%

Total operating revenue (YoY growth rate %)

Value142.08

Score3/3

Weight2.95%

1M Return1.27%

Inventory turnover ratio

Value98.02

Score3/3

Weight18.67%

1M Return6.81%

Gross profit margin (%)

Value35.31

Score1/3

Weight-2.23%

1M Return-1.03%

Income tax / Total profit (%)

Value-0.09

Score2/3

Weight-0.17%

1M Return-0.08%

Current assets turnover ratio

Value2.32

Score2/3

Weight1.09%

1M Return0.48%

Operating revenue (YoY growth rate %)

Value185.72

Score2/3

Weight0.77%

1M Return0.34%

Cost of sales ratio (%)

Value71.86

Score3/3

Weight8.69%

1M Return3.51%

Asset-MV

Value-0.49

Score3/3

Weight43.63%

1M Return14.53%

Cash-MV

Value0.01

Score2/3

Weight15.81%

1M Return5.85%

Is DMAC fundamentally strong?

DMAC scores 5.72/10 on fundamentals and holds a Fair valuation at present. Backed by its -67.68% ROE, 0.00% net margin, -10.66 P/E ratio, 6.22 P/B ratio, and -16.67% earnings growth, these metrics solidify its Netural investment rating.